Novo Biosciences, Inc.
Biotechnology company · Lamoine, Maine, United States
Novo Biosciences, Inc. is a biotechnology company headquartered in Lamoine, Maine, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2020.
Novo Biosciences at a glance
What does Novo Biosciences do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $4 million sold (2020).
Frequently asked questions about Novo Biosciences
Where is Novo Biosciences headquartered?
Novo Biosciences, Inc. is headquartered in Lamoine, Maine, United States.
What does Novo Biosciences do?
Novo Biosciences, Inc. is a biotechnology company.
When was Novo Biosciences founded?
The earliest incorporation on record for Novo Biosciences, Inc. is in 2013, according to public company registers.
Similar companies
- Revidia Therapeutics, Inc.Ellsworth, Maine, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences